• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • NEWROAD final meeting April 28, 2026
  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson’s disease and Diabetes Type 2Christos Andronis2020-08-03T13:44:46-04:00
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease.

Explore the live graph.

Tags: 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE, DIABETES TYPE 2, DIHYDROXYPHENYLALANINE, DOPAMINE, EXENATIDE, GLUCAGON-LIKE PEPTIDE 1, INSULIN, LEVODOPA, METFORMIN, NITRIC OXIDE, OXIDOPAMINE, PARKINSON'S DISEASE, SEROTONIN

Post navigation

← Rheumatoid Arthritis and Lupus
Parkinson’s disease and Autophagy →
THY-1 ANTIGENS TUMOR ULCERATIVE COLITIS WOUND HEALING TRASTUZUMAB TGF-BETA TUMOR GROWTH TARGET LESION IDENTIFICATION TRACHEA TUMOR PROGRESSION VEGF TISSUE DEVELOPMENT TRANSLATION TYPE 2 DIABETES THORAX TROGLITAZONE VGF PROTEIN THROMBIN VERO CELLS VASCULAR VASOCONSTRICTION VIRAL RELEASE FROM HOST CELL X-RAY COMPUTED TOMOGRAPHY UBIQUITINATION TECFIDERA VITAMIN D TROPISM UCHL1 PROTEIN TAU TIMELESS VASODILATION TP53 THROMBOCYTOPENIA TH17 CELLS THROMBOSIS TAUOPATHIES TMPRSS2 VIRUS DISEASES TRANSPORT VEGFA Uberon TREPONEMA DENTICOLA VEINS

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}